These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29881439)

  • 1. The frequency of
    Alblooshi H; Hulse G; Osman W; El Kashef A; Shawky M; Al Ghaferi H; Al Safar H; Tay GK
    Ann Gen Psychiatry; 2018; 17():22. PubMed ID: 29881439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control genome wide association study of substance use disorder (SUD) identifies novel variants on chromosome 7p14.1 in patients from the United Arab Emirates (UAE).
    Alblooshi H; Al Safar H; Fisher HF; Cordell HJ; El Kashef A; Al Ghaferi H; Shawky M; Reece S; Hulse GK; Tay GK
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jan; 180(1):68-79. PubMed ID: 30556296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study.
    Alblooshi H; Hulse GK; El Kashef A; Al Hashmi H; Shawky M; Al Ghaferi H; Al Safar H; Tay GK
    Subst Abuse Treat Prev Policy; 2016 May; 11(1):19. PubMed ID: 27177422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.
    Gao X; Wang Y; Lang M; Yuan L; Reece AS; Wang W
    OMICS; 2017 Jul; 21(7):404-412. PubMed ID: 28692418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between DRD2 and OPRM1 genotypes and adiposity.
    Hardman CA; Rogers PJ; Timpson NJ; Munafò MR
    Int J Obes (Lond); 2014 May; 38(5):730-6. PubMed ID: 23917806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of OPRM1 and DRD2 on brain structure in drug-naïve adolescents: Genetic and neural vulnerabilities to substance use.
    Picci G; Fishbein DH; VanMeter JW; Rose EJ
    Psychopharmacology (Berl); 2022 Jan; 239(1):141-152. PubMed ID: 34816289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
    Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
    J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes.
    Carpentier PJ; Arias Vasquez A; Hoogman M; Onnink M; Kan CC; Kooij JJ; Makkinje R; Iskandar S; Kiemeney LA; de Jong CA; Franke B; Buitelaar JK
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):448-57. PubMed ID: 22841130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descent.
    Alblooshi H; Al Safar H; El Kashef A; Al Ghaferi H; Shawky M; Hulse GK; Tay GK
    BMC Psychiatry; 2020 Jan; 20(1):41. PubMed ID: 32005204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.
    Colizzi M; Iyegbe C; Powell J; Ursini G; Porcelli A; Bonvino A; Taurisano P; Romano R; Masellis R; Blasi G; Morgan C; Aitchison K; Mondelli V; Luzi S; Kolliakou A; David A; Murray RM; Bertolino A; Di Forti M
    Schizophr Bull; 2015 Sep; 41(5):1171-82. PubMed ID: 25829376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients.
    Sasabe T; Furukawa A; Matsusita S; Higuchi S; Ishiura S
    Neurosci Lett; 2007 Jan; 412(2):139-42. PubMed ID: 17196743
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Masiak J; Chmielowiec J; Chmielowiec K; Grzywacz A
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33171585
    [No Abstract]   [Full Text] [Related]  

  • 14. The association between the OPRM1 A118G polymorphism and addiction in a Turkish population.
    Türkan H; Karahalil B; Kadıoğlu E; Eren K; Gürol DT; Karakaya AE
    Arh Hig Rada Toksikol; 2019 Jun; 70(2):97-103. PubMed ID: 31246565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opioid receptor mu 1 (OPRM1) rs1799971 and catechol-O-methyltransferase (COMT) rs4680 as genetic markers for placebo analgesia.
    Aslaksen PM; Forsberg JT; Gjerstad J
    Pain; 2018 Dec; 159(12):2585-2592. PubMed ID: 30130297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study analysis of DRD2 gene polymorphisms in drug addicted patients.
    Sznabowicz M; Jasiewicz A; Iskra-Trifunović J; Małecka I; Karakiewicz B; Kotwas A; Samochowiec J; Grzywacz A
    Psychiatr Pol; 2018 Dec; 52(6):1013-1022. PubMed ID: 30659563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent.
    Al-Eitan LN; Jaradat SA; Su SY; Tay GK; Hulse GK
    Pharmgenomics Pers Med; 2012; 5():99-111. PubMed ID: 23226066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.
    Wasilewski A; Lewandowska U; Mosinska P; Watala C; Storr M; Fichna J; Venkatesan T
    Am J Gastroenterol; 2017 Jun; 112(6):933-939. PubMed ID: 28349993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.
    Al-Eitan LN; Jaradat SA; Hulse GK; Tay GK
    BMC Res Notes; 2012 Sep; 5():497. PubMed ID: 22963930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between type 2 diabetes mellitus & TCF7L2 gene variants in the Emirati population: Genetics of diabetes in the United Arab Emirates.
    Khan SM; El Karte N; El Hajj Chehadeh S; Hassoun A; Afandi B; Tay GK; Alsafar H
    Am J Hum Biol; 2021 Jan; 33(1):e23434. PubMed ID: 32445548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.